VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RVTY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RVTYRevvity, Inc.
$155.11$17.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRVTYFinancials

Revvity, Inc. (RVTY) Income Statement

30Y historyFree accessUpdated daily

Revenue and gross margin have recovered from the depressed 43.8% reading in 2025Q4 to 57.4% in 2026Q3, though net margin of 8.5% still trails the 13-14% levels seen in 2024.

Income StatementBalance SheetCash FlowRatios

RVTY Income Statement

Annual statement

RVTY Income Statement

Revvity, Inc. (RVTY) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue2.94B2.86B2.76B2.75B3.31B3.83B3.78B2.88B2.78B2.26B2.12B2.1B2.24B2.17B2.12B1.92B1.7B1.55B1.96B1.79B1.55B1.47B1.43B1.54B1.5B1.33B1.7B1.36B1.41B1.46B1.43B
Revenue Growth %4.56%3.67%0.16%-16.95%-13.48%1.19%31.18%3.8%23.08%6.69%0.51%-5.92%3.28%2.41%10.09%12.73%9.9%-20.88%9.66%15.58%4.92%3.13%-6.91%2.01%13.15%-21.54%24.37%-3.18%-3.62%2.35%0.54%
Cost of Goods Sold1.38B1.34B1.43B1.43B1.55B1.55B1.79B1.59B1.53B1.23B1.14B1.17B1.27B1.23B1.19B1.1B963.91M851.78M1.12B1.07B922.89M859.29M846.33M906.27M904.1M721.73M918.43M787.3M991.3M1.04B1.01B
COGS % of Revenue-46.92%51.99%51.93%46.84%40.38%47.38%55.16%54.96%54.39%54.04%55.81%56.6%56.61%56.33%57.11%56.56%54.93%57.39%59.99%59.68%58.3%59.22%59.03%60.07%54.26%54.18%57.76%70.41%71.2%70.61%
Gross Profit1.56B1.52B1.32B1.32B1.76B2.28B1.99B1.29B1.25B1.03B972.25M930.03M971.01M939.97M923.81M823.98M740.43M698.98M835.07M715.14M623.47M614.54M582.76M628.95M600.88M608.33M776.84M575.8M416.6M420.7M419.5M
Gross Margin %53.07%53.08%48.01%48.07%53.16%59.62%52.62%44.84%45.04%45.61%45.96%44.19%43.4%43.39%43.67%42.89%43.44%45.07%42.61%40.01%40.32%41.7%40.78%40.97%39.93%45.74%45.82%42.24%29.59%28.8%29.39%
Gross Profit Growth %-14.62%0.04%-24.91%-22.84%14.64%53.94%3.34%21.56%5.87%4.54%-4.22%3.3%1.75%12.12%11.28%5.93%-16.3%16.77%14.7%1.45%5.45%-7.34%4.67%-1.22%-21.69%34.91%38.21%-0.97%0.29%3.07%
Operating Expenses1.19B1.16B912.14M922.7M979.61M941.95M970.72M887.57M880.27M724.72M666.58M663.24M740.51M681.22M723.02M706.04M567.67M558.89M633.76M540.49M471.97M452.83M444.68M495.22M540.87M492.46M592.81M464.4M322.7M332.9M331.8M
OpEx % of Revenue-40.6%33.11%33.55%29.58%24.61%25.66%30.78%31.69%32.11%31.51%31.51%33.1%31.45%34.18%36.75%33.31%36.04%32.33%30.24%30.52%30.72%31.12%32.26%35.94%37.03%34.97%34.07%22.92%22.79%23.25%
Selling, General & Admin976M945.28M715.3M706.12M757.99M741.61M765.33M698.24M694.17M585.56M542.8M551.2M619.97M548.69M590.89M590.92M473.86M468.11M524.82M430.57M373.85M365.46M362.32M386.4M431.3M411.14M418.98M327.1M226.3M243.4M290.9M
SG&A % of Revenue-33.1%25.96%25.67%22.89%19.37%20.23%24.21%24.99%25.94%25.66%26.19%27.71%25.33%27.94%30.76%27.8%30.19%26.78%24.09%24.18%24.8%25.35%25.17%28.66%30.91%24.71%24%16.07%16.66%20.38%
Research & Development213.15M215.84M196.84M216.58M221.62M200.34M205.39M189.34M186.1M139.16M123.78M112.04M120.54M132.52M132.14M115.12M93.81M90.78M108.94M109.92M98.12M87.37M82.36M83.14M86.45M81.31M86.12M71.2M46M44.9M0
R&D % of Revenue-7.56%7.14%7.87%6.69%5.23%5.43%6.57%6.7%6.17%5.85%5.32%5.39%6.12%6.25%5.99%5.5%5.85%5.56%6.15%6.35%5.93%5.76%5.42%5.74%6.11%5.08%5.22%3.27%3.07%-
Other Operating Expenses0-1.7M00000000000000000000025.67M23.11M087.72M66.1M50.4M44.6M40.9M
Operating Income372.09M356.63M410.52M399.49M781.12M1.34B1.02B405.48M370.97M304.63M305.67M266.79M230.49M258.76M200.78M117.94M172.76M140.09M201.31M174.65M151.5M161.71M138.09M183.91M123.37M197.58M184.03M104.4M31.7M121.6M87.7M
Operating Margin %12.65%12.49%14.9%14.52%23.59%35.01%26.96%14.06%13.35%13.5%14.45%12.68%10.3%11.95%9.49%6.14%10.14%9.03%10.27%9.77%9.8%10.97%9.66%11.98%8.2%14.86%10.86%7.66%2.25%8.32%6.14%
Operating Income Growth %--13.13%2.76%-48.86%-41.71%31.4%151.5%9.3%21.78%-0.34%14.57%15.75%-10.92%28.88%70.24%-31.73%23.32%-30.41%15.26%15.28%-6.31%17.11%-24.92%49.07%-37.56%7.37%76.27%229.34%-73.93%38.65%6.05%
EBITDA785.18M761.98M838.37M831.26M1.21B1.65B1.22B619.51M551.56M409.63M405.64M372.16M347.23M387.23M327.65M228.86M261.92M220.86M289.92M252.65M220.69M228.71M205.68M273.69M219.48M281.84M311.28M170.5M82.1M166.2M135.9M
EBITDA Margin %26.69%26.68%30.43%30.22%36.48%43.14%32.29%21.48%19.85%18.15%19.17%17.68%15.52%17.88%15.49%11.91%15.37%14.24%14.79%14.14%14.27%15.52%14.39%17.83%14.58%21.19%18.36%12.51%5.83%11.38%9.52%
EBITDA Growth %0.09%-9.11%0.86%-31.19%-26.84%35.2%97.16%12.32%34.65%0.98%9%7.18%-10.33%18.18%43.16%-12.62%18.59%-23.82%14.75%14.48%-3.51%11.19%-24.85%24.7%-22.13%-9.46%82.57%107.67%-50.6%22.3%14.49%
D&A (Non-Cash Add-back)413.09M405.34M427.85M431.77M427M311.44M201.65M214.03M180.59M105M99.97M105.36M116.74M128.47M126.86M110.92M89.16M80.76M88.61M78M69.18M67M67.6M89.78M96.11M84.26M127.25M66.1M50.4M44.6M48.2M
EBIT374.8M360.46M412.4M281.79M755.79M1.31B956.08M300.77M324.66M340.66M285.6M246.8M205.87M203.26M96.37M89.14M177.88M120.14M174.03M166.61M159.89M93.95M135.55M133.73M60.02M115.87M184.03M111.4M53.7M55.3M87.7M
Net Interest Income-71.17M-61.08M-23.09M-26.68M-100.37M-99.89M-48.7M-62.13M-65.83M-41.37M-40.83M-37.32M-35.6M-49.27M-45.04M-22.9M-15.06M-14.97M-21.2M000000000000
Interest Income20.86M31.1M73.19M72.13M3.59M2.24M1.01M1.5M1.14M2.57M702K673K667K650K747K1.88M832K1.03M4.02M4.69M9.39M3.32M2.4M00000000
Interest Expense92.03M92.19M96.28M98.81M103.95M102.13M49.71M63.63M66.98M43.94M41.53M38M36.27M49.92M45.79M24.78M15.89M17.16M82.14M41.7M0047.71M105.08M279.72M128.31M74.63M7M064.6M8.9M
Other Income/Expense-89.33M-88.36M-94.39M-216.51M-129.28M-136.42M-113.43M-168.34M-113.28M-7.92M-61.6M-57.98M-60.89M-105.42M-150.19M-53.59M-10.78M-33.96M-52.5M-23.36M-767K-95.05M-38.74M-56.39M-32.87M-163.43M-39.54M-66.5M124.3M-35.8M-7.3M
Pretax Income282.77M268.28M316.13M182.98M651.84M1.2B906.36M237.14M257.68M296.72M244.07M208.81M169.6M153.33M50.59M64.35M161.98M106.14M148.81M151.29M150.74M66.66M99.34M80.88M-8.55M34.15M144.49M44.9M156M54M80.4M
Pretax Margin %9.61%9.39%11.47%6.65%19.68%31.44%23.96%8.22%9.28%13.15%11.54%9.92%7.58%7.08%2.39%3.35%9.5%6.84%7.59%8.46%9.75%4.52%6.95%5.27%-0.57%2.57%8.52%3.29%11.08%3.7%5.63%
Income Tax27.41M25.8M33.05M3.47M139.16M314.15M178.27M9.39M20.21M139.83M28.36M20.02M8.44M-14.59M-17.85M63.18M26.06M31.8M21.04M17.45M32.41M128K23.46M25.87M-4.42M34.77M58.42M16.5M54M23.4M25.9M
Effective Tax Rate %9.69%9.62%10.46%1.9%21.35%26.1%19.67%3.96%7.84%47.12%11.62%9.59%4.97%-9.52%-35.29%98.18%16.09%29.96%14.14%11.54%21.5%0.19%23.62%31.99%51.64%101.82%40.43%36.75%34.62%43.33%32.21%
Net Income253.2M241.68M295.83M-118.38M569.18M943.16M728.1M227.56M238.79M113.02M233.68M212.45M158.04M167.92M68.44M1.17M383.92M85.6M128.41M132.92M117.15M81.75M75.88M52.96M-4.13M-620K90.52M28.4M102M33.7M60.2M
Net Margin %8.61%8.46%10.74%-4.3%17.19%24.64%19.25%7.89%8.6%5.01%11.05%10.09%7.06%7.75%3.24%0.06%22.53%5.52%6.55%7.44%7.58%5.55%5.31%3.45%-0.27%-0.05%5.34%2.08%7.24%2.31%4.22%
Net Income Growth %5.88%-18.31%349.91%-120.8%-39.65%29.54%219.96%-4.7%111.28%-51.64%9.99%34.43%-5.89%145.36%5739.68%-99.69%348.51%-33.34%-3.39%13.46%43.31%7.73%43.28%1380.75%-566.94%-100.68%218.73%-72.16%202.67%-44.02%10.87%
Net Income (Continuing)255.36M242.48M283.07M179.5M512.68M889.44M728.1M227.75M237.47M156.89M215.71M188.78M161.17M167.92M68.44M1.17M135.92M74.33M127.77M133.83M118.32M66.53M75.88M55.01M-4.13M-620K86.07M28.4M79M9.6M54.5M
Discontinued Operations-1.5M-975K12.76M-297.88M56.5M53.72M0-195K1.31M-43.87M17.97M23.67M-3.13M000248M11.26M633K-916K-1.17M15.21M000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)2.262.082.41-0.954.508.086.492.042.141.022.121.871.391.480.600.013.250.731.061.100.930.620.580.41-0.03-0.010.890.311.110.370.64
EPS Growth %13.31%-13.69%353.87%-121.09%-44.31%24.47%218.23%-4.67%110%-51.87%12.98%34.93%-6.08%148.28%5685.44%-99.68%345.21%-31.13%-3.82%19.02%48.54%7.48%41.46%1346.2%--100.64%187.1%-72.07%200%-42.19%25.49%
EPS (Basic)-2.082.41-0.954.518.126.532.052.161.032.131.891.401.500.600.013.280.741.071.120.940.630.600.42-0.03-0.010.920.311.130.370.64
Diluted Shares Outstanding111.83M113.21M122.82M124.81M126.43M116.67M112.08M111.5M111.53M110.86M110.31M113.31M113.74M113.5M114.86M113.86M117.98M116.59M118.69M120.81M125.88M131.43M129.79M129.17M125.57M107.83M101.71M91.3M91.89M91.08M94.8M
Basic Shares Outstanding111.6M113.21M122.76M124.7M126.16M116.17M111.51M110.83M110.56M109.86M109.48M112.51M112.59M112.25M113.73M112.98M117.11M116.25M117.66M118.92M125.2M129.27M127.34M126.09M125.57M104.56M98.39M91.3M90.27M91.08M94.8M
Dividend Payout Ratio-13.57%11.65%-6.21%3.43%4.29%13.65%12.99%27.25%13.18%14.86%20.01%18.82%46.61%2715.78%8.59%38.2%25.76%25.36%30.26%44.4%47.16%66.86%--30.42%89.79%24.9%76.26%44.19%

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Tariff and China exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Re-Accelerating After Divestiture Reset

Based on Revvity's reported figures, quarterly revenue rose from $664.8M in 2025Q1 to $728.9M in 2026Q3, a 4.3% year-over-year gain that suggests the post-divestiture base is now growing again.

The revenue series shows a pattern of modest but steady expansion, with year-over-year growth of 7.0% in 2026Q1 moderating to 4.3% in 2026Q3. This deceleration may reflect tougher comparisons against the strong 2025Q4 quarter rather than a loss of demand. Investors should monitor whether organic growth is distinguishable from transition service agreement income and FX effects before treating the trend as durable.

Gross Margin Recovering Toward Structural Levels

As reported in the financial statements, gross margin moved from a depressed 43.8% in 2025Q4 back to 57.4% in 2026Q3, suggesting mix and cost normalization after the divestiture.

The sharp 2025Q4 compression to 43.8% appears inconsistent with the otherwise stable 53-57% range, which may indicate one-time inventory or cost items rather than structural pressure. The recovery to 57.4% is consistent with a higher-margin reagent and informatics mix. Sustaining this level depends on continued reagent pull-through and avoiding renewed input cost inflation.

Operating Leverage Visible but Uneven

According to recent SEC filings, operating margin improved from 10.7% in 2026Q1 to 13.1% in 2026Q3, with SG&A holding near $275M, indicating some operating leverage on flat-to-rising revenue.

Because gross profit grew faster than operating expenses over the most recent quarters, incremental revenue appears to be converting into operating income at a higher rate. However, operating income remained volatile across the ten-quarter window, with 2025Q4 and 2024Q4 showing unusually high margins that appear driven by lower SG&A rather than sustained efficiency. Investors should treat the latest margin as encouraging but not yet a proven steady state.

EPS Beat Partly Reflects Operating Momentum

Based on Revvity's reported figures, diluted EPS of $0.56 in 2026Q3 rose 40% year over year, but net margin of 8.5% remains well below the 13-14% peaks seen in 2024.

The EPS growth rate is amplified by a low prior-year base, so the 40% figure overstates the underlying improvement. Net income has grown more slowly than operating income in recent quarters, which may point to higher interest, tax, or non-operating drag. Stock-based compensation of roughly $10M per quarter is modest but warrants watching alongside the reported EPS trajectory.

Structural Growth Ceiling Risks

Based on reported quarterly data, Revvity's revenue has grown only 0.5% to 7% year over year in recent periods, which may leave limited room for error if tariff or China-related headwinds intensify.

Newborn screening volumes tied to declining birth rates could cap organic growth in the Diagnostics segment, a core profit contributor. Peer data shows Waters and Mettler-Toledo sustaining higher operating margins near 28%, suggesting Revvity's 13% operating margin still has room to lag if pricing power weakens. Investors should monitor whether the recent guidance raise reflects durable demand or temporary timing benefits.

RVTY — Frequently Asked Questions

Quick answers to the most common questions about buying RVTY stock.

What was Revvity, Inc.'s (RVTY) revenue in 2025?

For fiscal year 2025, Revvity, Inc. (RVTY) reported total revenue of $2.86B. This represents a 100.1% increase compared to $1.43B in 1996.

Is Revvity, Inc. (RVTY) profitable?

Revvity, Inc. (RVTY) is profitable, generating $241.7M in net income for the fiscal year ending 2025 with a net profit margin of 8.5%.

What is Revvity, Inc.'s operating profit margin?

Revvity, Inc. (RVTY) reported an operating income of $356.6M, resulting in an operating profit margin of 12.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Revvity, Inc.'s gross profit and gross margin?

Revvity, Inc. (RVTY) generated $1.52B in gross profit for the year, representing a gross profit margin of 53.1%. This demonstrates the company's core pricing power and production efficiency.